Literature DB >> 9486606

High-dose preoperative radiation and the challenge of sphincter-preservation surgery for cancer of the distal 2 cm of the rectum.

M Mohiuddin1, W F Regine, G J Marks, J W Marks.   

Abstract

PURPOSE: Sphincter-preserving surgery for the management of distal rectal cancer is gaining recognition as an alternative to abdominoperineal resection and loss of anal function. The use of high-dose preoperative radiation appears to enhance the options for sphincter preservation, even in the most distal segments of the rectum.
MATERIALS AND METHODS: Seventy patients with tumors located in the distal 2 cm of the rectum received a minimum dose of 40 to 45 Gy over 4 1/2 weeks at 1.8 to 2.5 Gy per fraction. Patients with unfavorable tumors were given an additional boost of 10 to 15 Gy. Surgery was performed 5 to 10 weeks following completion of radiation. Radical surgical resection was performed in 48 patients and full thickness local excision in 22. Follow-up ranged from a minimum of 1 year to a maximum of 10 years, with a median of 4 years.
RESULTS: There was one perioperative mortality. Two patients did not have their colostomy closed because of complications. Late diversion was required in 4 patients, primarily for recurrent disease. Sixty patients (86%) maintained long-term satisfactory sphincter function. Local recurrence was observed in 9 patients (13%) and distant metastases in 12 patients (17%). The overall five-year actuarial survival rate was 82%. The 5-year survival and local recurrence for postradiation pathological stage of disease was: T0, T1, T2, N0--95% and 8%, T3, T4, N0--91% and 4%, T(any) N+--50% and 41%, respectively.
CONCLUSION: High-dose preoperative radiation, in properly selected patients with rectal cancers of the distal 2 cm, offers opportunities for sphincter-preserving surgical resection with excellent local control, survival, and enhanced quality of life.

Entities:  

Mesh:

Year:  1998        PMID: 9486606     DOI: 10.1016/s0360-3016(97)00842-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Local treatment for rectal cancer.

Authors:  Daniel P Geisler
Journal:  Clin Colon Rectal Surg       Date:  2007-08

2.  Integrated ¹⁸F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology.

Authors:  Michael A Fischer; Bart Vrugt; Hatem Alkadhi; Dieter Hahnloser; Thomas F Hany; Patrick Veit-Haibach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-24       Impact factor: 9.236

3.  Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy.

Authors:  Jong Wan Kim; Hyun Chul Kim; Ji Won Park; Sung Chan Park; Dae Kyung Sohn; Hyo Seong Choi; Dae Yong Kim; Hee Jin Chang; Ji Yeon Baek; Sun Young Kim; Seok Ki Kim; Jae Hwan Oh
Journal:  Int J Colorectal Dis       Date:  2013-02-13       Impact factor: 2.571

4.  Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.

Authors:  E Rullier; B Goffre; C Bonnel; F Zerbib; M Caudry; J Saric
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

5.  Sphincter-sparing surgery for adenocarcinoma of the distal 3 cm of the true rectum: results after neoadjuvant therapy and minimally invasive radical surgery or local excision.

Authors:  John Marks; George Nassif; Henry Schoonyoung; Al DeNittis; Eric Zeger; Mohammed Mohiuddin; Gerald Marks
Journal:  Surg Endosc       Date:  2013-09-21       Impact factor: 4.584

6.  Low-lying rectal cancer with anal canal involvement: abdominoperineal or low anterior resection after neoadjuvant chemoradiotherapy.

Authors:  Ly Do; Nisar Syed; Ajmel Puthawala; Samar Azawi; Imad Shbeeb; I-Yeh Gong
Journal:  Gastrointest Cancer Res       Date:  2011-05

7.  Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer.

Authors:  C Pericay; X Serra-Aracil; J Ocaña-Rojas; L Mora-López; E Dotor; A Casalots; A Pisa; E Saigí
Journal:  Clin Transl Oncol       Date:  2015-10-26       Impact factor: 3.405

8.  Preoperative concomitant radiotherapy with oral capecitabine in advanced rectal cancer within 6 cm from anal verge.

Authors:  Walid Galal Elshazly; Mohmed Farouk; Mohmed Samy
Journal:  Int J Colorectal Dis       Date:  2008-12-16       Impact factor: 2.571

9.  Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.

Authors:  Holger Amthauer; Timm Denecke; Beate Rau; Bert Hildebrandt; Michael Hünerbein; Juri Ruf; Ulrike Schneider; Matthias Gutberlet; Peter M Schlag; Roland Felix; Peter Wust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-05       Impact factor: 9.236

Review 10.  Sphincter preservation in rectal cancer.

Authors:  C G Willett
Journal:  Curr Treat Options Oncol       Date:  2000-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.